United States .. A cancer drug license "from its origins"

The US Food and Drug Administration (FDA) has announced that it has obtained a drug manufacturing license for the treatment of malignancies.

In a statement released Monday, November 26, the new drug, Vitrakvi, is able to eliminate the genetic factors responsible for cancer, making it the first drug to treat the disease at the source and root.

International medical organizations and institutions are striving to find a drug that can cure the disease, for which science has so far been unable to find a drug, with the exception of doses of chemicals that may not be available. to be effective in all cases.

The FDA reported that the new drug had been tested on a girl with cancer and had been cured seven months later.

The FDA is expected to release the drug in the form of capsules or adult tablets in the form of liquid syrup for infected children.

Scott Gottlieb, Commissioner of the US Food and Drug Administration, said: "The approval of this drug is an important step in the treatment of cancer because it treats it from its source and treats the foundation of cancerous tumors, which whatever their location in the human body. "

He added that the drug would treat different types of cancer in people with common genetic mutations.

The World Health Organization considers that cancer is the second leading cause of death in the world, making 8.8 million victims by 2015.

Of the six deaths in the world, one is the cause of the disease and the organization expects to increase the incidence of cancer by 70% over the next two decades.

–

If you think the article contains incorrect information or if you have additional details, send a correction.